MacroGenics, Inc. Alternatives & Competitors

12 companies similar to MacroGenics, Inc. — Developing immunotherapeutics to prevent autoimmune disorders, cancer and infect...

Xencor

Proteins by Design

303 Post-IPO Equity $482.60M

Pasadena, United States

Biotechnology Health Care +1

Greywolf Therapeutics

We are advancing novel antigen modulation technology that controls T cells to guide the im...

49 Series B $107.10M

United Kingdom

Biotechnology Health Care +1

NEOVACS

Nous développons les thérapies de demain et investissons dans des sociétés innovantes en B...

18 Post-IPO Equity $37.95M

Suresnes, France

Biotechnology Health Care +2

MabGenesis Inc.

Discovery of innovative therapeutic antibodies for human and animal health

3 Series A $277.50M

Yokohama, Japan

Biopharma Biotechnology +2

Track all MacroGenics, Inc. competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Ichor Biologics

Accelerating cures for infectious diseases

New York, United States

Biotechnology Health Care +1

Novavax

Powering innovation. Protecting health.

970 Post-IPO Equity $2.71B

Gaithersburg, United Stat...

Biotechnology Health Care +1

Biotheus Inc.

To Inspire Each Other and Create Effective Medicines for Humankind

24 Acquired $919.50M

Zhuhai, China

Biotechnology Health Care

FibroGen, Inc.

Committed to being a place where our people and science thrive.

347 Post-IPO Equity $308.02M

San Francisco, United Sta...

Biopharma Biotechnology +2

Alder Biopharmaceuticals

Dedicated to alleviating human suffering with safer and better antibody therapeutics throu...

Post-IPO Equity $916.50M

Biotechnology Health Care +1

Tavotek Biotherapeutics

Innovative Therapies. Better Health.

8 Series B $55.00M

United States

Biopharma Biotechnology +2

Abpro

Developing antibody therapies to improve the lives of patients facing severe and life-thre...

39 Venture round $40.39M

Woburn, United States

Biotechnology Health Care +1

Innovent Biologics

To develop and commercialize high-quality biopharmaceuticals that are affordable to ordina...

846 Post-IPO Equity

Suzhou, China

Biopharma Biotechnology +1

About MacroGenics, Inc.

MacroGenics, Inc. is at the forefront of developing immunotherapeutics aimed at combating autoimmune disorders, cancer, and infectious diseases. With a focus on next-generation antibody-based technologies, the company has built a robust pipeline of product candidates targeting cancer treatment.

Services

Development of next-generation protein-based therapies, Clinical trials in cancer and autoimmune disorders, Partnerships with global biopharmaceutical companies

Target Customers

Cancer Patients, Hematology Patients, Autoimmune Disorder Patients, Biopharmaceutical Partners, Healthcare Providers

Taxonomy

Immunotherapeutics, Autoimmune Disorders, Cancer Treatment, Infectious Diseases, Monoclonal Antibodies, Fc Engineering Technology, Dual Activating ReTargeting Technology, Bi-Specific Antibodies, Antibody-Based Technologies, Vaccine Development, Pharmaceutical Partnerships, Drug Development, Product Pipeline Advancement, Innovative Medicines

Business Model

B2B, Platform

Revenue Model

Licensing, Performance Based

Frequently Asked Questions

Companies similar to MacroGenics, Inc. include Xencor, Greywolf Therapeutics, NEOVACS, MabGenesis Inc., Ichor Biologics. They work in Biotechnology and Health Care and share MacroGenics, Inc.'s focus on cancer treatment, monoclonal antibodies and infectious diseases.

Bounce Watch lists 12 companies that share MacroGenics, Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches MacroGenics, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

MacroGenics, Inc. Profile Xencor Alternatives Greywolf Therapeutics Alternatives NEOVACS Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at MacroGenics, Inc. on 23 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.